Evidence map›Paper›PMID 33233756›Full record

ArticleMolecules (Basel, Switzerland)2020

Development and Optimization of Epigallocatechin-3-Gallate (EGCG) Nano Phytosome Using Design of Experiment (DoE) and Their In Vivo Anti-Inflammatory Studies.

Mohammad H Shariare, Kazi Afnan, Faria Iqbal, Mohammad A Altamimi, Syed Rizwan Ahamad, Mohammed S Aldughaim, Fars K Alanazi, Mohsin Kazi

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Green Tea: Current Knowledge and Issues.Foods (Basel, Switzerland) · 2025
    Review
  11. Review
  12. Review
  13. Review
  14. Fabrication of Phytosome with Enhanced Activity ofInternational journal of nanomedicine · 2024
    Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Nano-Nutraceuticals for Health: Principles and Applications.Revista brasileira de farmacognosia : orgao oficial da Sociedade Brasileira de Farmacognosia · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Mohammad H ShariareDepartment of Pharmaceutical Sciences, North South University, Dhaka 1229, Bangladesh.ORCID 0000-0001-5176-3647
Kazi AfnanDepartment of Pharmaceutical Sciences, North South University, Dhaka 1229, Bangladesh.
Faria IqbalDepartment of Pharmaceutical Sciences, North South University, Dhaka 1229, Bangladesh.
Mohammad A AltamimiDepartment of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Syed Rizwan AhamadCentral Laboratory, Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0002-4519-0069
Mohammed S AldughaimResearch Center, King Fahad Medical City, P.O. Box. 59046, Riyadh 11525, Saudi Arabia.
Fars K AlanaziDepartment of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Mohsin KaziDepartment of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0002-5611-0378
King Saud University · SANorth South University · BDKing Fahd Medical City · SA

Funding

Deanship of Scientific Research, King Saud University IFKSURG-1435-017
6 · The paper itself

Abstract

Inflammation is responsible for the development of many diseases that make up a significant cause of death. The purpose of the study was to develop a novel nanophytosomal preparation of epigallocatechin-3-gallate (EGCG) and egg phospholipid complex that has a lower particle size with higher drug loading capability, physical stability and anti-inflammatory activities. The impact of different factors and material characteristics on the average particle size was studied along with the drug loading of phytosome using design of experiment (DoE). The in vivo anti-inflammatory study was evaluated using a rat model to investigate the performance of EGCG nanophytosome. UHPLC results showed that 500 µg of EGCG were present in 1 mL of green tea extract. SEM data exhibited that phytosome (phospholipid-drug complex) was in the nanosize range, which was further evident from TEM data. Malvern Zetasizer data showed that the average particle size of the EGCG nanophytosome was in the range of 100-250 nm. High drug loading (up to 90%) was achieved with optimum addition rate, stirring temperature and phospholipid concentration. Stability study data suggest that no significant changes were observed in average particle size and drug loading of nanophytome. The in vivo anti-inflammatory study indicated a significant anti-inflammatory activity of green tea extract, pure EGCG and its phytosomal preparations (

Indexed as

Anti-Inflammatory AgentsCatechinChromatography, High Pressure LiquidDrug CarriersGas Chromatography-Mass SpectrometryNanoparticlesParticle SizePhytochemicalsAnti-Inflammatory AgentsCatechinDrug Carriersepigallocatechin gallatePhytochemicalsanti-inflammatorydrug loadingepigallocatechin-3-gallate (EGCG)nanophytosomeparticle size

Identifiers

PMID33233756
PMCPMC7699940
OpenAlexW3098217234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.